Finance

Lists
539730:BOM
Fredun Pharmaceuticals Ltd
₹1 485,90
-1,19%
(-17,90) 1D
13 Okt., 10:31:14 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 539730...
Open
₹1 535,00
High
₹1 535,00
Low
₹1 476,60
Mkt. cap
24,80 mjd
Avg. vol.
18,42 k
Volume
4,32 k
P/E ratio
55,42
52-wk high
₹1 666,35
52-wk low
₹454,05
EPS
₹26,81
Shares outstanding
3,99 m
No. of employees
736
Open
₹1 535,00
High
₹1 535,00
Low
₹1 476,60
Mkt. cap
24,80 mjd
Avg. vol.
18,42 k
Volume
4,32 k
P/E ratio
55,42
52-wk high
₹1 666,35
52-wk low
₹454,05
EPS
₹26,81
Shares outstanding
3,99 m
No. of employees
736
News stories
From web sources and news partners
About Fredun Pharmaceuticals Ltd
CEO-
Employees736
Founded1987
Headquarters-
SectorPharmaceutical industry
Last report
13 Aug. 2026
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
2,28 mjd / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
1,44 mjd
1,60 mjd
2,13 mjd
2,28 mjd
Cost of goods sold
1,09 mjd
1,15 mjd
1,60 mjd
1,77 mjd
Cost of revenue
1,09 mjd
1,15 mjd
1,60 mjd
1,77 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
82,99 m
81,46 m
484,22 m
71,21 m
Operating expense
163,40 m
210,93 m
270,90 m
216,29 m
Total operating expenses
1,25 mjd
1,36 mjd
1,87 mjd
1,99 mjd
Operating income
187,30 m
235,55 m
252,32 m
286,78 m
Other non operating income
17,06 m
9,97 m
-49,65 m
4,92 m
EBT including unusual items
127,05 m
140,02 m
112,48 m
205,52 m
EBT excluding unusual items
127,05 m
140,02 m
112,48 m
205,52 m
Income tax expense
32,74 m
35,24 m
53,02 m
74,20 m
Effective tax rate
25,77%
25,17%
47,14%
36,10%
Other operating expenses
61,48 m
111,63 m
-244,82 m
109,37 m
Net income
94,32 m
104,78 m
59,45 m
131,32 m
Net profit margin
6,57%
6,55%
2,80%
5,77%
Earnings per share
-
-
-
-
Interest and investment income
-
-
6,60 m
-
Interest expense
-77,31 m
-105,50 m
-126,75 m
-86,18 m
Net interest expenses
-77,31 m
-105,50 m
-120,15 m
-86,18 m
Depreciation and amortization charges
18,93 m
17,84 m
31,50 m
35,71 m
EBITDA
203,86 m
247,83 m
272,79 m
307,24 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme